Urokinase plasminogen activator expression by primary and HPV 16-transformed keratinocytes.
The molecular events underlying progression of human papillomavirus (HPV) 16-associated intraepithelial neoplasia to invasive cancer have not been studied in detail. Penetration of the basement membrane is an early, but poorly understood step in this process and probably involves the action of one or more metallo- and serine proteinases. Urokinase-type plasminogen activator (uPA) is a serine proteinase that has been implicated in the pathogenesis of several epithelial tumors, but its role in HPV-associated tumors is not known. To examine uPA expression by HPV 16-transformed keratinocytes in vitro, primary foreskin keratinocyte cultures were transfected by HPV 16 DNA. The primary parental cells and the HPV 16-transformed keratinocytes were studied using substrate gel zymography, Western blot analysis and an in vitro assay measuring penetration of a Matrigel artificial basement membrane. Both uPA and its inhibitor, plasminogen activator inhibitor-1 (PAI-1), were overexpressed in the HPV 16-transformed cells relative to the parental cell line. The transformed cells, but not the parental cells, were able to degrade and penetrate the Matrigel membrane and penetration was blocked by both PAI-1 and by antibodies to uPA. Our data suggest that HPV 16-induced transformation of keratinocytes is associated with upregulation of uPA expression. In conjunction with other proteinases, uPA plays an important role in the ability of HPV 16-transformed keratinocytes to penetrate artificial basement membranes.
Turner
M A
MA
Department of Laboratory Medicine, University of California, San Francisco 94143, USA.
Palefsky
J M
JM
D001485:Basement Membrane / Q000502:physiology; D015153:Blotting, Western; D002472:Cell Transformation, Viral / Q000502:physiology*; D002478:Cells, Cultured; D004279:DNA, Viral / Q000235:genetics; D006133:Growth Substances / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D015603:Keratinocytes / Q000166:cytology / Q000201:enzymology* / Q000821:virology*; D008297:Male; D008567:Membranes, Artificial; D008853:Microscopy; D027383:Papillomaviridae / Q000235:genetics / Q000502:physiology*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D014162:Transfection; D014568:Urokinase-Type Plasminogen Activator / Q000502:physiology*
D004279:DNA, Viral; D006133:Growth Substances; D008567:Membranes, Artificial; D015842:Serine Proteinase Inhibitors; D014568:Urokinase-Type Plasminogen Activator